Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy

American Journal of Ophthalmology

Volumn 135, Issue 2, 2003, Pages 188-193

  Koga, Takahisa ^a   Ando, Eiko ^b   Hirata, Akira ^a   Fukushima, Mikiko ^a   Kimura, Akira ^a   Ando, Yukio ^a   Negi, Akira ^c   Tanihara, Hidenobu ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b Nishinihon Hospital   (Japan)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; METHIONINE; TYROSINE; VALINE;

ADULT; AGED; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; FOLLOW UP; HUMAN; LENS IMPLANT; MALE; MUTATION; PHACOEMULSIFICATION; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREOUS OPACITY;

ADULT; AGED; AMYLOID; AMYLOID NEUROPATHIES, FAMILIAL; EYE DISEASES; FEMALE; HUMANS; LENS IMPLANTATION, INTRAOCULAR; MALE; MIDDLE AGED; PHACOEMULSIFICATION; PREALBUMIN; PREVALENCE; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 0037310462     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)01838-X     Document Type: Article

References (25)

1. Andrade C. A peculiar form of peripheral neuropathy. Brain. 75:1952;408-427.
2. Araki S. Type I familial amyloidotic polyneuropathy (Japanese type). Brain Dev. 6:1984;128-133.
3. Yoshioka K., Furuya H., Sasaki H., et al. Haplotype analysis of familial amyloidotic polyneuropathy. Evidence for multiple origins of the Val-Met mutation most common to the disease. Hum Genetics. 82:1989;9-13.
4. Connors L.H., Richardson A.M., Theberge R., Costello C.E. Tabulation of transthyretin (TTR) variants as of 1/1/2000. Amyloid. 7:2000;54-69.
5. Ando E., Ando Y., Maruoka S., et al. Ocular microangiopathy in familial amyloidotic polyneuropathy, type I. Graefes Arch Clin Exp Ophthalmol. 230:1992;1-5.
6. Lessell S., Wolf P.A., Benson M.D., Cohen A.S. Scalloped pupils in familial amyloidosis. N Engl J Med. 293:1975;914-915.
7. Futa R., Inada K., Nakashima H., et al. Familial amyloidotic polyneuropathy ocular manifestations with clinicopathological observation. Jpn J Ophthalmol. 28:1984;289-298.
8. Sandgren O., Eriksson A. Lacrimal dysfunction in familial amyloidotic polyneuropathy (FAP), Swedish type. Costa P.P., Freitas A.S., Saraiva M.J.M. Familial amyloidotic polyneuropathy and other transthyretin disorders. 1990;329-333 Arquivous de Medicina, Porto.
9. Tsukahara S., Matsuo T. Secondary glaucoma accompanied with primary familial amyloidosis. Ophthalmologica. 175:1977;250-262.
10. Wong V.G., McFarlin D.E. Primary familial amyloidosis. Arch Ophthalmol. 78:1967;208-213.
11. Sandgren O. Vitreous opacity in familial amyloidotic polyneuropathy, Swedish type. Costa P.P., Freitas A.S., Saraiva M.J.M. Familial amyloidotic polyneuropathy and other transthyretin disorders. 1990;309-312 Arquivous de Medicina, Porto.
12. Sandgren O., Holmgren G., Lundgren E. Vitreous amyloidosis associated with homozygosity for the transthyretin methionine-30 gene. Arch Ophthalmol. 108:1990;1584-1586.
13. Ando E., Ando Y., Okamura R., et al. Ocular manifestations of familial amyloidotic polyneuropathy type I long-term follow up. Br J Ophthalmol. 81:1997;295-298.
14. Ueno S., Uemichi T., Yorifuji S., Tarui S. A novel variant of transthyretin (Tyr114 to Cys) deduced from the nucleotide sequences of gene fragments from familial amyloidotic polyneuropathy in Japanese sibling cases. Biochem Biophys Res Commun. 169:1990;143-147.
15. Ueno S., Fujimura H., Yorifuji S., et al. Familial amyloidotic polyneuropathy associated with the transthyretin Cys114 gene in a Japanese kindred. Brain. 115:1992;1275-1289.
16. Felding P., Fex G. Cellular origin of prealbumin in the rat. Biochim Biophys Acta. 716:1982;446-449.
17. Borek C., Smith J.E., Soprano D.R., Goodman D.S. Regulation of retinol-binding protein metabolism by glucocorticoid hormones in cultured H4II EC3 liver cells. Endocrinology. 109:1981;386-391.
18. Soprano D.R., Herbert J., Soprano K.J., et al. Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. J Biol Chem. 260:1985;11793-11798.
19. Herbert J., Wilcox J.N., Pham K.T., et al. Transthyretin a choroid plexus-specific transport protein in human brain. Neurology. 36:1986;900-911.
20. Cavallaro T., Martone R.L., Dwork A.J., et al. The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye. Invest Ophthalmol Vis Sci. 31:1990;497-501.
21. Ong D.E., Davis J.T., O'Day W.T., Bok D. Synthesis and secretion of retinol-binding protein and transthyretin by cultured retinal pigment epithelium. Biochemistry. 33:1994;1835-1842.
22. Ando Y., Okamura R., Ando E., et al. Changes of the retina in gene carriers and patients with familial amyloidotic polyneuropathy (FAP). Costa P.P., Freitas A.S., Saraiva M.J.M. Familial amyloidotic polyneuropathy and other transthyretin disorders. 1990;313-315 Arquivous de Medicina, Porto.
23. Monteiro J.G., Ferreira A.P., Figueira A.S., et al. Vitreous opacities in familial amyloid polyneuropathy. Costa P.P., Freitas A.S., Saraiva M.J.M. Familial amyloidotic polyneuropathy and other transthyretin disorders. 1990;323-328 Arquivous de Medicina, Porto.
24. Holmgren G., Ericzon B.G., Groth C.G., et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet. 341:1993;1113-1116.
25. Ando Y., Tanaka Y., Ando E., et al. Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I. Lancet. 345:1995;195-196.